Impax Laboratories Inc (NASDAQ:IPXL)

Data as of Jan 30
 -1.02 / -2.71%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Generic

Company Description

Impax Laboratories, Inc. operates as a technology based specialty pharmaceutical company, which engages in the development, manufacture and marketing of controlled-release and niche generics. It operates through two divisions: Global Pharmaceuticals and Impax Pharmaceuticals. The Global Pharmaceuticals Division concentrates its efforts on the development, manufacture, sale and distribution of its generic products, which are the pharmaceutical and therapeutic equivalents of brand-name drug products. The Impax Pharmaceuticals Division focuses on the development of proprietary brand pharmaceutical products addressing central nervous system disorders. The company was founded on December 14, 1999 and is headquartered in Hayward, CA.

Contact Information

Impax Laboratories, Inc.
30831 Huntwood Avenue
Hayward California 94544-7003
P:(510) 240-6000
Investor Relations:
(215) 558-4526



Mutual fund holders50.69%
Other institutional34.37%
Individual stakeholders13.23%

Top Executives

George Frederick WilkinsonPresident, Chief Executive Officer & Director
Bryan M. ReasonsChief Financial Officer & Senior Vice President
Jeffrey D. NornholdSenior Vice President-Technical Operations
Mark A. SchlossbergSecretary, Senior Vice President & General Counsel
Michael J. NestorPresident-Impax Pharmaceuticals Division

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.